| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/04/2006 | US7022706 Central nervous system disorders |
| 04/04/2006 | US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 04/04/2006 | US7022345 Oral solid pharmaceutical formulations with pH-dependent multiphasic release |
| 04/04/2006 | US7022338 A pressed tablet was prepared in low pressure, no heat generated, with the help by adding oligosaccharides, polysaccharides, and adding slime-forming agent for targeting gastro-intestinal tract; Streptococcus, Lactobacillus, Bifidobacterium; stable viability; biodrugs |
| 04/04/2006 | US7022108 Method for delivery of therapeutic and/or diagnostic agents |
| 04/04/2006 | CA2341031C Novel salt form of pantoprazole |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2193039C Indol-2-one derivatives |
| 03/30/2006 | WO2006034440A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 03/30/2006 | WO2006033951A1 Lactobacillus and atopobium compositions for maintaining and restoring normal gastrointestinal flora |
| 03/30/2006 | WO2006033949A1 Lactobacillus iners for reduction of human malodor |
| 03/30/2006 | WO2006033631A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| 03/30/2006 | WO2006033630A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
| 03/30/2006 | WO2006033453A1 Activity enhancer for interferon agent |
| 03/30/2006 | WO2006033081A2 Peroxisome proliferation receptor agonists, for the treatment of gastritis |
| 03/30/2006 | WO2005068612A3 Human hepatic progenitor cells and methods of use thereof |
| 03/30/2006 | WO2005018342A8 Compositions and methods for the maintenance of oral health |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069146 Cardiovascular disordders; antiarrhythmia agents; neurodegenerative diseases; antidepressants; bipolar disorders; irritable bowel disorders |
| 03/30/2006 | US20060069140 Pyrazolone compounds and thrombopoietin receptor activator |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069130 Novel crystals |
| 03/30/2006 | US20060069126 Pharmaceutically active isoindoline derivatives |
| 03/30/2006 | US20060069120 Novel piperidine derivaties as modulators of chemokine receptor ccr5 |
| 03/30/2006 | US20060069092 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 03/30/2006 | US20060069062 toothpastes, mouthwashes, chewing gums, tableted candy, for inhibiting induction of dental caries |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060067921 Probiotic bacterium: lactobacillus fermentum |
| 03/30/2006 | US20060067913 HCV therapy |
| 03/30/2006 | DE102004043945A1 Mund-, Zahn- und Zahnprotesenpflegemittel enthaltend die Plaquebildung inhibierende Substanzen Oral, dental and Zahnprotesenpflegemittel containing plaque formation inhibiting substances |
| 03/30/2006 | CA2582507A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
| 03/30/2006 | CA2581319A1 Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| 03/30/2006 | CA2580855A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 03/29/2006 | EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line |
| 03/29/2006 | EP1640381A2 Neurotrophic growth factor |
| 03/29/2006 | EP1640010A1 Agent inducing increase in bone mass |
| 03/29/2006 | EP1638607A1 Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
| 03/29/2006 | EP1638603A1 Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 03/29/2006 | EP1638594A1 Hip/pap polypeptide composition for use in liver regeneration and for the prevention of liver failure |
| 03/29/2006 | EP1638542A1 Use of n-alkanols as activators of the cftr channel |
| 03/29/2006 | EP1523311B1 Calcium lactate and whey permeate for lowering the triglyceride level |
| 03/29/2006 | EP1409539B1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 03/29/2006 | EP1305402B1 Lipo-viro-particle complexes, preparation method and uses |
| 03/29/2006 | EP1265483B1 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces |
| 03/29/2006 | EP1251750B1 Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 03/29/2006 | EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor |
| 03/29/2006 | EP1105105B1 Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
| 03/29/2006 | EP1077715B1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 03/29/2006 | EP0990031B1 Tumor necrosis factor receptor 5 |
| 03/29/2006 | EP0918797B1 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 03/29/2006 | CN1753893A The enantiomer of tenatoprazole and the use thereof in therapy |
| 03/29/2006 | CN1753886A Process for producing acid adduct salt of polyacidic base compound |
| 03/29/2006 | CN1753680A Derivatives of prostaglandins for treating abdominal discomfort |
| 03/29/2006 | CN1753674A Use of tenatoprazole for the treatment of gastroesophageal reflux |
| 03/29/2006 | CN1753656A Bioadhesive liquid composition which is substantially free of water |
| 03/29/2006 | CN1751735A Traditional Chinese medicine-Liganlong oral liquor for treating hepatopathy and its prepn. method |
| 03/29/2006 | CN1751734A Traditional Chinese medicine prepn. for treating lithiasis and its prepn. method |
| 03/29/2006 | CN1751733A Soft capsule of traditional Chinese medicine Angong Niuhuang and its prepn. method |
| 03/29/2006 | CN1751725A Medicinal food product for preventing and treating major kakostomia and constipation, and its prepn. method |
| 03/29/2006 | CN1751724A Shuanghuang Zhenbei powder medicine |
| 03/29/2006 | CN1751718A Traditional Chinese medicine composition, prepn. method and quality control method therefor |
| 03/29/2006 | CN1751715A Method for testing and controlling quality of medicine schisantherin |
| 03/29/2006 | CN1751711A Process for producing toxins eliminating agent |
| 03/29/2006 | CN1751710A Novel administration route of injection-free type used in summer, prepn. process and indication thereof |
| 03/29/2006 | CN1751693A Application of astragaloside in medicine for treating or preventing insulin resistance |
| 03/29/2006 | CN1247780C Mammalian sytokine-like polypeptide-10 |
| 03/29/2006 | CN1247606C Two (Z)-4-hydroxycinnamic acid glycosides and their application |
| 03/29/2006 | CN1247593C Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 03/29/2006 | CN1247577C Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247570C Novel pyridyl cyanoguandine compounds |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/29/2006 | CN1247256C Pharmaceutical combination for treatment of tissue damage owing to arterial irrigation defect |
| 03/29/2006 | CN1247246C Medicine for treating cholecystitis |
| 03/29/2006 | CN1247242C Medicine for easing pain and reinforcing teeth |
| 03/29/2006 | CN1247241C Liuwei Dihuang dripping pills |
| 03/29/2006 | CN1247240C Herbal medicine compositions for treatment allergic rhinitis and use thereof |
| 03/29/2006 | CN1247234C Medicine for treating children's microelement deficiency and its processing method |
| 03/29/2006 | CN1247215C Medicine for treating mouth mucous ulcer |
| 03/29/2006 | CN1247212C Thermal therapeutical medicated bag for recovering intestines and stomach function after abdomen operation and production method |
| 03/29/2006 | CN1247211C Health-care or medicinal tablet containing active ganoderma extract |
| 03/29/2006 | CN1247208C Preparation method of silkworm dropping soluble preparation |
| 03/29/2006 | CN1247206C Health-care food and its production method |
| 03/29/2006 | CN1247205C Sea cucumber carotenoid lipid fraction products and method of use |
| 03/29/2006 | CN1247195C Silibinin oral disintegration tablet and its preparing method |
| 03/29/2006 | CN1247191C Hydroxy diphenyl ether compound |
| 03/29/2006 | CN1247185C Aqueous solution extracted from nucleus of hawthorn stone as fluid for protecting teeth |
| 03/29/2006 | CN1247183C Dental products comprising bone growth enhancing peptide |
| 03/29/2006 | CN1247121C Longan aril and wolfberry fruit polysaccharide health-care liquid preparing method |
| 03/29/2006 | CN1247116C Bottom stuff of midicinal meal for fire pot and preparation method |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019013 Sulfamidothienopyrimidines |
| 03/28/2006 | US7019007 CCR-3 receptor antagonists (I) |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor |
| 03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |